Bausch Health Companies | VRX - Ebitda

Prix De L'Action
7.69
Variation Quotidienne
0.10 1.32%
Mensuellement
9.54%
Annuel
2.12%
Q2 Prévisions
7.53




Ebitda Changement Date
Amgen USD 5.14B 775M 2025-12
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Aurora Cannabis CAD 18.48M 3.11M 2025-12
Bausch Health Companies USD 986M 74M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Canopy Growth CAD -2.87M 19.49M 2025-12
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Danaher USD 1.92B 204M 2026-03
Drreddys Laboratories INR 21.59B 1.49B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Gilead Sciences USD 3.02B 1.01B 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novo Nordisk DKK 37.3B 5.86B 2025-12
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 90.82M 3.99M 2025-12
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09
Zoetis USD 1.04B 87M 2025-09